← Leaderboards
Elizabeth A Thomas
Scripps Research Institute
$4,837,155
Attributed
$4,837,155
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $605.3K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,837,155 · 4
By mechanism
R01$3,891,155 · 2
R21$946,000 · 2
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute
Same institution · by research overlap
- Kim D Janda$47,128,009
- Rebecca Page$4,994,451
- Jack C Sipe$1,266,644
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionGenesBrainMessenger RnaIn Situ HybridizationProteinsPathologic ProcessCellsHuntington DiseaseMutantLengthAffectCag RepeatMotorLeadLaboratory MouseBaseDisease PhenotypeCorpus Striatum StructureBiological MarkersDesignEnzyme-Linked Immunosorbent AssayClinical TrialsHuman Huntingtin Protein
Grant awards (16)
Exploration of salivary huntingtin for biomarker discovery$193,125
R21 · FY2020 · NS · contact PI
Exploration of salivary huntingtin for biomarker discovery$231,750
R21 · FY2019 · NS · contact PI
Disease Modifying Potential of Glatiramer Acetate in Huntington's disease$236,875
R21 · FY2015 · NS · contact PI
Disease Modifying Potential of Glatiramer Acetate in Huntington's disease$284,250
R21 · FY2014 · NS · contact PI
Towards Mechanistic Explanations of Striatal Disorders$427,275
R01 · FY2010 · NS · contact PI
Towards Mechanistic Explanations of Striatal Disorders$427,275
R01 · FY2009 · NS · contact PI
Schizophrenia: Molecular Markers of Disease Progression$283,918
R01 · FY2008 · MH · contact PI
Schizophrenia: Molecular Markers of Disease Progression$282,022
R01 · FY2007 · MH · contact PI
Towards Mechanistic Explanations of Striatal Disorders$300,659
R01 · FY2006 · NS · contact PI
Schizophrenia: Molecular Markers of Disease Progression$290,445
R01 · FY2006 · MH · contact PI
Towards Mechanistic Explanations of Striatal Disorders$307,895
R01 · FY2005 · NS
Schizophrenia: Molecular Markers of Disease Progression$297,435
R01 · FY2005 · MH
Schizophrenia: Molecular Markers of Disease Progression$350,546
R01 · FY2004 · MH
Towards Mechanistic Explanations of Striatal Disorders$307,895
R01 · FY2004 · NS
Towards Mechanistic Explanations of Striatal Disorders$307,895
R01 · FY2003 · NS
Towards Mechanistic Explanations of Striatal Disorders$307,895
R01 · FY2002 · NS